New Drug Review: Clobazam (Onfi®) - A “new” anticonvulsant option

Clobazam was approved by the Food and Drug Administration (FDA) in October of 2011. This article reviews clinically significant aspects of this new drug including: the FDA-approved indications, mechanism of action, administration, drug interactions, adverse effects, clinical trial evidence, innovati...

Full description

Saved in:
Bibliographic Details
Published inThe mental health clinician Vol. 1; no. 6; pp. 126 - 127
Main Authors Holmes, Jamie, Hieber, Robin
Format Journal Article
LanguageEnglish
Published 01.12.2011
Online AccessGet full text

Cover

More Information
Summary:Clobazam was approved by the Food and Drug Administration (FDA) in October of 2011. This article reviews clinically significant aspects of this new drug including: the FDA-approved indications, mechanism of action, administration, drug interactions, adverse effects, clinical trial evidence, innovative properties and place in therapy.
ISSN:2168-9709
2168-9709
DOI:10.9740/mhc.n89385